Back to VTRSView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
1 competitor in Chronic Obstructive Pulmonary Disease, COPD
View Full LandscapeDrug Information
Target Indication
Chronic Obstructive Pulmonary Disease, COPD
Clinical Trial
NCT03095456Last updated: 12/19/2025
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
MYL-1601D ProductPhase 3
Diabetes Mellitus, Type 1
venlafaxine ER 75 mg/day (fixed dose)Phase 3
Major Depressive Disorder
LATANOPROST 0.005% / TIMOLOL 0.5% FIXED COMBINATIONPhase 3
Glaucoma, Primary Open Angle (POAG)
Econazole Nitrate Cream, 1%Phase 3
Tinea Pedis
Amlodipine/atorvastatin single pillPhase 3
Hypertension
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts